ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2026
Antimicrobial stewardship in community pharmacies in Uyo, Akwa Ibom State: practices, barriers, and facilitators.
Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the practices, barriers, and facilitators related to antimicrobial stewardship (AMS) in community pharmacies (CPs). Design: Cross-sectional study. Setting: CPs in Uyo, Akwa Ibom State, Nigeria. Participants: One hundred and twelve pharmacists working in CPs, who had been practicing for at least six months and gave informed consent to participate, were surveyed. Methods: Potential participants were approached at their CPs during working hours and the study's objectives explained to them. Data were collected using a 31-item self-administered questionnaire from October to November 2023 and analyzed with SPSS version 25.0. Result: Participants were predominantly male (61.6%). Eighty-seven (77.7%) indicated that they often/always encourage patients to run a culture/sensitivity test before taking antibiotics. Most (95.5%) indicated that their choice of antibiotics is based on such results. The most frequently cited barriers to implementing AMS in CPs were limited access to patient records (93.8%), unrestricted patient access to antimicrobials without a prescription (90.1%), and physicians' resistance to pharmacists intervening in antibiotic selection (58.0%) or the dose/duration of prescribed antibiotics (50.9%). The most commonly reported facilitators of AMS were increased availability of pharmacy education programs on AMS (92.9%), improved access to patients' clinical/laboratory data (88.4%), improved collaboration with physicians in hospitals (85.7%), and public awareness initiatives emphasizing the role of community pharmacists in AMS (85.7%). Conclusion: Participants reported generally favorable AMS practices. However, tailored AMS education programs for pharmacists and the general public, along with stronger collaboration between pharmacists and physicians and between CPs and hospitals are recommended.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.